Join Experts and Patients in NYC for a Day of Learning and Connecting Register Free Today
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Find clinical trials that match your diagnosis, stage and treatment history.
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
Days 4 and 5 at ASCO17 showed off the overall scope of immunotherapy’s efforts to provide clinical benefits to patients. Many next-generation immune-based treatments were discussed, including some of which may represent the future standard of care for some cancers. Below are some of the most important findings revealed during the final two days of the conference:
Multiple Tumor Types:
Watch our story about Carol, one of the patients treated on this trial.
Head and Neck Cancer:
ASCO17: Day 3 Immunotherapy Highlights
Read Previous Article
ASCO17 Recap: 7 Takeaways from the World’s Premier Clinical Cancer Conference
Read Next Article
*Immunotherapy results may vary from patient to patient.
National Headquarters | One Exchange Plaza
55 Broadway, Suite 1802 | New York, NY 10006
(800) 992-2623(212) 832-9376Staff Directory
Biomarkers will be crucial to taking advantage of combination immunotherapy’s full potential
Nivolumab becomes second checkpoint immunotherapy approved for colorectal cancer